Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Revitalist Lifestyle and Wellness Ltd (OP: RVLWF )

N/A UNCHANGED
Last Price Updated: 3:48 PM EST, Feb 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0390
Today's Range N/A - N/A
52wk Range 0.0100 - 0.0375
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Psyched: Clinical-Grade MDMA, LSD For Depression, Partnerships For Delivering Psychedelic Therapies & More
Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules 
Via Benzinga
EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
At the second edition of Benzinga’s Psychedelics Capital Conference, held in sunny Miami, leaders from four major ketamine therapy companies shared their optimistic insights and guidance about the... 
Via Benzinga

Performance

More News

Read More
Joint Venture Partnership Expands Access To Psychedelics Therapy For Some 50K Patients
Via Benzinga
Revitalist Announces Closing of Private Placement
From Revitalist Lifestyle and Wellness Ltd.
Via Business Wire
Women's Footprint In Psychedelics Is Undeniable, Benzinga's Psychedelics Advisory Council's Six New Trailblazers
Via Benzinga
Largest Psychedelic Stocks DOWN 8% Last Week; DOWN 22% So Far This Month
Via Talk Markets
Major Psychedelic Drug Stocks DOWN 9% Last Week; Now Down 51% YTD
Via Talk Markets
Psychedelic Drug Stocks Index Has A Good Week
Via Talk Markets
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
Via Benzinga
New Collaboration Will Bring Psychedelic Clinics & Retreats With Vertical Offerings To The U.S.
Via Benzinga
Revitalist and Wake Network Announce Joint Venture Partnership to Open Psychedelic Clinics and Retreats in the United States
From REVITALIST LIFESTYLE AND WELLNESS LTD.
Via Business Wire
Psychedelics Company Launches New Supplements Line, Joins Global Wellness Market
Via Benzinga
Ketamine Therapy: Revitalist's New Financing Option, Irwin Naturals Expands Chain Of Clinics
Via Benzinga
What Are The Best Psychedelic-Assisted Therapy Clinics In The World? Here Are 5 To Check Out
Via Benzinga
Psychedelic Drug Stocks Index Up Slightly This Week
Via Talk Markets
Justice Dept Grants $1M To Non-Profits To Help Stem Teen Mental Health Issues & School Violence
Via Benzinga
Revitalist Non-Profit, “Community Change Foundation”, Receives $1M Grant to Address Adolescent Mental Health and School Violence
From Revitalist
Via Business Wire
Psychedelic Stocks Continue To Plummet: -16% This Week; -33% MTD; Now -57% YTD
Via Talk Markets
Psychedelics Companies Are Teaming Up To Offer Access Veterans
Via Benzinga
Revitalist and Wake Network Enter Joint Venture Offering National and International Access to Psychedelics for Veterans
From Revitalist Lifestyle and Wellness Ltd.
Via Business Wire
Revitalist Achieves 300% Month Over Month Growth Serving Veterans with Psychedelic Therapies in the US with Coverage from VA
From Revitalist Lifestyle and Wellness Ltd.
Via Business Wire
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
Via Benzinga
Awakn Enters U.S. Addiction Treatment & Relapse Prevention Market With Ketamine Therapy For Alcohol Use Disorder
Via Benzinga
Revitalist Announces Release of Three Proprietary Service Lines Advancing Their Comprehensive Footprint in the Mental Health and Psychedelic Wellness Space
From Revitalist Lifestyle and Wellness Ltd.
Via Business Wire
10 Psychedelics CEOs To Pay Attention To In 2022
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.